ACET Q3 2017 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$3,000

Operating Income

-$4M

Net Income

-$3M

EPS (Diluted)

$-1.92

QoQ Revenue Growth

-100.0%

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$128M	-100.0%
Gross Profit	-$3,000	$31M	-100.0%
Operating Income	-$4M	$9M	-145.0%
Net Income	-$3M	$4M	-175.5%

Revenue Segments

Human Health

$106M57%

Performance Chemicals

$43M23%

Pharmaceutical Ingredients

$37M20%